Table: OncoTherapy Science -2018/19 parent results
May 10 (Reuters)-
OncoTherapy Science Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2019 Mar 31, 2018 Mar 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 205 mln 205 mln
(-0.3 pct) (-28.3 pct)
Operating loss 2.18 loss 2.70
Recurring loss 2.17 loss 2.68
Net loss 3.40 loss 2.63
EPS loss 23.05 yen loss 17.85 yen
Ann Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - OncoTherapy Science Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T